ST2 as a Marker for Risk of Therapy-Resistant Graft-Versus-Host Disease and Death

Study Questions:

What is the role of plasma biomarkers in characterizing the response of acute graft-versus-host-disease (GVHD) to therapy after allogeneic hematopoietic stem-cell transplantation?